InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.67
(
0.00%
)
US TECH 100
17,585.60
(
-0.15%
)
Dow Jones
39,056.39
(
0.44%
)
Brent Oil
83.74
(
0.21%
)
Bitcoin
61,533.26
(
0.57%
)
Post# of 251756
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119593
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biocqr post# 225375

Tuesday, 06/25/2019 9:58:30 AM

Tuesday, June 25, 2019 9:58:30 AM

Post# of 251756
ABBV-AGN PR on $63B buyout:

https://finance.yahoo.com/news/abbvie-acquire-allergan-transformative-move-104200213.html

Under the terms of the Transaction Agreement, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan…for a total consideration of $188.24 per Allergan Share [based on ABBV’s 6/24/19 closing price]. The transaction represents a 45% premium to the closing price of Allergan's Shares on June 24, 2019.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up